Adaptimmune Therapeutics plc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -3.06 | -100% |
| P/S |
|
1.66 | 33.58 | -95.05% |
|
|
| P/BV |
|
2.54 | 4.79 | -46.91% |
|
|
| P/FCF |
|
-1.21 | 61 | -101.99% |
|
|
| Ev/Ebitda |
|
0.1424 | -17.26 | -100.83% |
|
|
| Ev/S |
|
-0.3011 | 22.5 | -101.34% |
|
|
| Ev/FCF |
|
0.1245 | 69 | -99.82% |
|
|
| E/P |
|
-0.6447 | 0.0178 | -3727.27% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-211.37 | 4.97 | -4351.12% | -3024.1 | -93.01% |
| ROE |
|
-289.3 | 9.61 | -3109.94% |
|
|
| ROA |
|
-40.45 | 0.3443 | -11849.26% |
|
|
| ROIC |
|
-65.72 | 7.63 | -960.85% |
|
|
| ROS |
|
-188.9 | -25.17 | 650.49% |
|
|
| ROCE |
|
-348.66 | 15.19 | -2395.93% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1973 | -3.67 | -94.62% | -0.4712 | -58.13% |
| Nеt Debt/Ebitda |
|
0.9284 | -4.06 | -122.88% |
|
|
| Debt/Ratio |
|
0.0893 | 0.199 | -55.13% |
|
|
| Debt/Equity |
|
0.0988 | 1.54 | -93.6% |
|
|
| Debt/Net Income |
|
-0.2208 | 10.34 | -102.13% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
5928.1 | 76.2 | 7679.66% | ||
| Growth impulse Ebitda in 5 years |
|
1.64 | 44.75 | -96.34% | ||
| Growth impulse Net Income in 5 years |
|
-16.88 | -15.36 | 9.9% | ||
| Growth impulse FCF in 5 years |
|
25.66 | -108.72 | -123.6% | ||
| Growth impulse EPS in 5 years |
|
-57.1 | -142.05 | -59.8% |
IP Score
3.66/10
